Erin Nicole Young
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Erin Nicole Young has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Amandeep Bajwa
The University of Tennessee Health Science Center
1 shared publication - Canan Kuscu
Transplant Research Institute, Department of Surgery, University of Tennessee Health Science Center, Memphis, TN 38163, United States
1 shared publication - Cem Kuscu
Transplant Research Institute, James D. Eason Transplant Institute, Department of Surgery, College of Medicine, The University of Tennessee Health Science Center, Memphis, TN 38163, USA
1 shared publication - Christine Watkins
Transplant Research Institute, James D. Eason Transplant Institute, Department of Surgery, College of Medicine, The University of Tennessee Health Science Center, Memphis, TN 38163, USA
1 shared publication - Constantine Asahngwa
Division of Health Policy and Research, Nkafu Policy Institute, Yaoundé, Cameroon
1 shared publication - Denis Alemka Foretia
Division of Health Policy and Research, Nkafu Policy Institute, Yaoundé, Cameroon
1 shared publication
Latest Publications
- Open Access
- 29 April 2026
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 88 (6) , 3506-3511
Gallbladder agenesis: a systematic review of presentation, management, and outcomes
Introduction: Gallbladder agenesis (GA) is often misdiagnosed as a gallbladder pathology. This systematic review aimed to summarize the current evidence on epidemiology, clinical presentation, diagnostic approaches, and management strategies. Methods: PubMed/MEDLINE, Scopus, and Embase databases were comprehensively searched in English, French, and Spanish for GA cases published before November 2022. Two reviewers screened articles using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Data were analyzed to identify the clinical features, diagnostic approaches, management strategies, and associated factors. Results: A total of 9186 unique articles were screened, 125 of which met the inclusion criteria (151 cases in total). Most patients were female (66%), with a median age of 45 years. Most patients (73%) were diagnosed intraoperatively, and the most common presenting symptoms were right upper quadrant pain (66%), nausea (32%), or emesis (30%). Less than 15% of patients had elevated liver enzyme levels or leukocytosis. Ultrasonography was the primary imaging modality (81%). Most patients (79%) underwent operative management, with laparoscopy in 49.6% and exploratory laparotomy in 50.4%. Diagnosis by hepatobiliary iminodiacetic acid scan was associated with higher complications (odds ratio 8.53, 95% confidence interval 1.21–59.1, P = 0.026). There were more complications in the US cohort than in the non-US cohort (20% vs. 4.5%, P = 0.006). Conclusions: This systematic review showed that many patients with GA underwent unnecessary operative interventions with an associated increase in complications. Surgeons should be familiar with this diagnosis to minimize unnecessary interventions and reduce healthcare costs.
- 29 April 2026
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 88 (6) , 3506-3511
Open AccessGallbladder agenesis: a systematic review of presentation, management, and outcomes
Introduction: Gallbladder agenesis (GA) is often misdiagnosed as a gallbladder pathology. This systematic review aimed to summarize the current evidence on epidemiology, clinical presentation, diagnostic approaches, and management strategies. Methods: PubMed/MEDLINE, Scopus, and Embase databases were comprehensively searched in English, French, and Spanish for GA cases published before November 2022. Two reviewers screened articles using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Data were analyzed to identify the clinical features, diagnostic approaches, management strategies, and associated factors. Results: A total of 9186 unique articles were screened, 125 of which met the inclusion criteria (151 cases in total). Most patients were female (66%), with a median age of 45 years. Most patients (73%) were diagnosed intraoperatively, and the most common presenting symptoms were right upper quadrant pain (66%), nausea (32%), or emesis (30%). Less than 15% of patients had elevated liver enzyme levels or leukocytosis. Ultrasonography was the primary imaging modality (81%). Most patients (79%) underwent operative management, with laparoscopy in 49.6% and exploratory laparotomy in 50.4%. Diagnosis by hepatobiliary iminodiacetic acid scan was associated with higher complications (odds ratio 8.53, 95% confidence interval 1.21–59.1, P = 0.026). There were more complications in the US cohort than in the non-US cohort (20% vs. 4.5%, P = 0.006). Conclusions: This systematic review showed that many patients with GA underwent unnecessary operative interventions with an associated increase in complications. Surgeons should be familiar with this diagnosis to minimize unnecessary interventions and reduce healthcare costs.
- Open Access
- 5 October 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (19) , 11805
A Review of Defatting Strategies for Non-Alcoholic Fatty Liver Disease
Non-alcoholic fatty liver disease is a huge cause of chronic liver failure around the world. This condition has become more prevalent as rates of metabolic syndrome, type 2 diabetes, and obesity have also escalated. The unfortunate outcome for many people is liver cirrhosis that warrants transplantation or being unable to receive a transplant since many livers are discarded due to high levels of steatosis. Over the past several years, however, a great deal of work has gone into understanding the pathophysiology of this disease as well as possible treatment options. This review summarizes various defatting strategies including in vitro use of pharmacologic agents, machine perfusion of extracted livers, and genomic approaches targeting specific proteins. The goal of the field is to reduce the number of necessary transplants and expand the pool of organs available for use.
- 5 October 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (19) , 11805
Open AccessA Review of Defatting Strategies for Non-Alcoholic Fatty Liver Disease
Non-alcoholic fatty liver disease is a huge cause of chronic liver failure around the world. This condition has become more prevalent as rates of metabolic syndrome, type 2 diabetes, and obesity have also escalated. The unfortunate outcome for many people is liver cirrhosis that warrants transplantation or being unable to receive a transplant since many livers are discarded due to high levels of steatosis. Over the past several years, however, a great deal of work has gone into understanding the pathophysiology of this disease as well as possible treatment options. This review summarizes various defatting strategies including in vitro use of pharmacologic agents, machine perfusion of extracted livers, and genomic approaches targeting specific proteins. The goal of the field is to reduce the number of necessary transplants and expand the pool of organs available for use.